Why does Tyler Klimas call the hemp-cannabis regulatory debate 'distracting and cannibalistic'?

Klimas uses this characterization to describe the dynamic in which the hemp and cannabis industries are spending political and advocacy energy fighting each other rather than working toward the cohesive cannabinoid regulatory framework that would benefit both sectors. The debate is 'distracting' because it consumes legislative attention at a critical inflection point when both federal and state policy is in flux, and 'cannibalistic' because hemp and cannabis businesses effectively compete for the same consumer market and the same regulatory attention. The confusion created by regulatory disparities between the two sectors makes it harder for lawmakers to understand the industry, harder for businesses to plan, and harder for advocates to make progress on the more fundamental issues of federal reform and cannabis regulatory burden reduction. Klimas expresses optimism that this is 'a small era in a decades-long history' that the industry will work through.

How did hemp-derived THC products develop with fewer regulations than licensed cannabis?

The regulatory gap emerged from the scope of authority granted to agricultural departments over hemp. These agencies received oversight of hemp cultivation — the plant in the field — but their jurisdiction was not extended to finished consumer products derived from hemp. Cannabis regulatory agencies, meanwhile, had authority only over cannabis-derived products. Hemp-derived cannabinoid products — including delta-8 THC, delta-10 THC, and hemp-derived delta-9 THC beverages — fell into the space between these two regulatory structures. Agricultural agencies lacked authority over finished consumer products; cannabis agencies lacked authority over hemp-derived products. The result was a market where hemp-derived products containing psychoactive cannabinoids could reach mainstream retail channels without the consumer product testing, labeling, packaging, and retail controls that apply to licensed cannabis.

What does 'bidirectional regulatory reform' mean for hemp and cannabis industries?

Klimas argues that solving the hemp-cannabis regulatory tension requires movement in both directions: hemp-derived products need increased regulation to establish consumer protection standards comparable to licensed cannabis, while licensed cannabis needs meaningfully reduced regulatory burdens that currently disadvantage it relative to hemp products operating under agricultural rules. Simply bringing hemp-derived products under existing cannabis regulatory frameworks without also reforming those frameworks would push products into a system that Klimas characterizes as 'not working very well for the cannabis industry right now' due to federal restrictions. Many hemp industry stakeholders support increased hemp regulations — they recognize that consumer safety standards and product integrity requirements benefit responsible operators and build the consumer trust that sustains the market long-term.

How do hemp-derived THC beverages represent an opportunity rather than a threat for cannabis?

Klimas reframes hemp-derived THC beverage success as market intelligence rather than competitive threat: 'One benefit or positive for hemp is giving us a look into a whole new consumer base that has not historically accessed traditional cannabis retail dispensaries.' The success of THC beverages in mainstream retail settings like Total Wine reveals that a significant consumer segment exists for cannabinoid products delivered through familiar formats in conventional retail channels — consumers who are interested in cannabinoids but do not visit dispensaries. This insight could inform cannabis regulatory reform: if the goal is consumer safety and market access, understanding where consumers actually are and what formats they prefer is more valuable than viewing hemp's retail channel access as simply an unfair advantage.

How does Qredible's platform help businesses navigate hemp-cannabis regulatory uncertainty?

For businesses operating in either the hemp or cannabis space during this period of regulatory uncertainty, Q-Trust's policy-first architecture provides specific structural advantages. When regulations change — as they inevitably will across both hemp and cannabis frameworks — compliance parameters update automatically from the policy layer via compliance bulletins rather than requiring engineering redeployment. Q-Trust's state-by-state legal status matrix tracks product eligibility jurisdiction by jurisdiction — critical for hemp-derived products where state regulatory treatment varies from agricultural commodity to cannabis equivalent to outright prohibition. Q-Audit's continuous monitoring ensures that when a state's regulatory treatment of a specific product category changes, compliance alerts surface immediately rather than being discovered during periodic reviews. Q-Certification converts this continuous compliance monitoring into a living credential that retail partners, financial institutions, and regulatory agencies can verify in real time — reducing the uncertainty that Klimas identifies as the core business planning challenge.

Hemp Cannabis Regulatory Gaps: Opportunities and Coexistence

The Hemp-Cannabis Coexistence Challenge: Regulatory Gaps and Opportunities

Category: Business Learning Center Videos

Author: Joy

Date: March 11, 2025

As the cannabis and hemp industries expand across the United States, businesses face significant regulatory challenges that affect their operations, compliance efforts, and long-term sustainability. During a recent Qredible Live Broadcast, Tyler Klimas, principal and founder of Leaf Street Strategies and former head of the Nevada Cannabis Compliance Board, shared expert insights on the hemp cannabis regulatory gaps, the critical issues affecting both sectors, and how they might find common ground.

The Current State of Hemp and Cannabis Regulation

The relationship between hemp and cannabis industries has become one of the most pressing concerns for stakeholders across both sectors. This tension stems largely from regulatory disparities that have created market imbalances.

"I think the whole debate is distracting. I think it's cannibalistic in a way," Klimas explained during the broadcast. "It's confusing, especially for lawmakers, and it's causing a considerable amount of chaos at really an inflection point in the advocacy world for cannabis and cannabinoids in general."

A significant challenge lies in how hemp and cannabis products are regulated at the state level. While most states task agricultural departments with hemp cultivation oversight, these agencies typically don't have jurisdiction over finished consumer products.

"Hemp itself should be regulated in a different agency... but never the final product. That's been the huge gap here," Klimas noted. "If you have a cannabis regulatory agency and you have your Department of Agriculture regulating hemp... that was until you chopped the plant off the stock. They didn't have jurisdiction over a final product. In fact, they didn't contemplate final consumable products in many cases."

The Regulatory Gap Challenge

Hemp cannabis regulatory gaps have led to a situation where hemp-derived products containing THC isomers can sometimes be sold with fewer restrictions than state-licensed cannabis products, creating friction between the sectors.

Klimas pointed out that this situation calls for a balanced approach: "Rules and regulations need to be increased on the hemp side. I think a lot of hemp stakeholders would agree with that. I think a lot of hemp stakeholders are pushing for that. On the flip side, the regulatory burdens need to be reduced significantly for legal cannabis."

Finding a Balance

Creating a cohesive regulatory framework that accommodates both industries requires thoughtful consideration of various factors:

Shared Regulatory Oversight

Some states are exploring bringing hemp-derived consumer products under cannabis regulatory agencies. While this approach could ensure consistent safety standards, Klimas expressed caution about this solution:

"From an outsider's perspective, knowing that our cannabis regulatory structures, mostly because of federal restrictions, are not working very well for the cannabis industry right now, it's hard to make a considerate effort to push something under that type of system."

Learning From Each Industry

Despite the tensions, both industries have valuable insights to offer each other:

"We'll learn a lot from this hemp-cannabis regulatory gaps debate. We'll learn a lot being what is hemp doing right, a lot of times because they're not under the same regulatory restrictions. But maybe that gives us some great insight on what regulations we need to take off the books for cannabis," Klimas suggested.

The Consumer Perspective

The debate between hemp and cannabis has revealed important consumer trends that could inform future regulatory frameworks. For example, hemp-derived THC beverages have found success in conventional retail settings:

"One benefit or positive for hemp is giving us a look into a whole new consumer base that has not historically accessed traditional cannabis retail dispensaries," Klimas observed. "The success of THC beverages being sold in big-box stores like Total Wine shows people are consuming those and want those, and those are not normally the consumers that go into dispensaries."

Federal Uncertainty Complicates State Solutions

Adding to the complexity is the ongoing uncertainty at the federal level. While some positive signals have emerged, including both major presidential candidates discussing cannabis reform during the 2024 election cycle, the path forward remains unclear.

"We're just not going to get that clarity until something concrete happens," Klimas said regarding federal cannabis policy. He mentioned that the pending decision on cannabis rescheduling could serve as "an indicator" of future federal direction.

Best Practices for Businesses in an Uncertain Environment

For companies operating in either the hemp or cannabis space, Klimas offered several insights:

Stay informed about regulatory developments at both state and federal levels
Engage with industry associations to help shape policy discussions
Consider the full consumer experience beyond just traditional dispensary models
Prepare for eventual regulatory changes by building adaptable compliance systems

Inevitable Integration

Despite current tensions, Klimas expressed optimism that the industries will eventually find common ground:

"We're going to get to a spot. This is going to be a small era in a decades-long history of the industry, so we're going to work through it."

The current debate, while challenging, may eventually lead to a more cohesive approach to cannabinoid regulation that serves public health while allowing businesses in both sectors to thrive. The experiences in states like Nevada, which has implemented comprehensive cannabis regulations including testing requirements for terpenes and other quality attributes beyond just THC content, offer valuable models for this future integration.

As Klimas summarized: "In a perfect world, this is our opportunity to accomplish that and do that, but in practical nature, it's just much more difficult. These states were not set up to regulate this kind of entire cannabinoid industry."

For businesses operating in these sectors, staying informed, engaged with regulators, and focused on consumer safety will be key strategies for successfully adapting to the changing regulatory environment.